ACTRN12607000577415尚未招募未知
EFFICACY AND SAFETY OF INTRAVITREAL AVASTIN IN EYES WITH NEOVASCULAR GLAUCOMA UNDERGOING AHMED GLAUCOMA VALVE IMPLANTATIO
Dr. Enyr Saran Arcieri0 个研究点目标入组 35 人开始时间: 2007年11月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 90 Years（—）
- 性别
- All
入选标准
- •All patients with uncontrolled neovascular glaucoma that underwent prior pan retinal photocoagulation requiring glaucoma drainage device implantation will be eligible.
排除标准
- •Patients younger than 18 years; with learning difficulties, mental illness, or dementia; unconscious; or severely ill will not be included in the study.
研究者
相似试验
招募中
不适用
Clinical study of the Avastin intravitreal injection to thick macula after surgery of epiretinal membraneEpiretinal MembraneJPRN-UMIN000015286Okayama University Hospital30
进行中（未招募）
不适用
Evaluation of safety and efficacy of intravitreal bevacizumab for macular edema, retinal or choroidal neovascularization or neovascular glaucoma - NDMacular oedemaMedDRA version: 6.1Level: HLGTClassification code 10047060EUCTR2006-002351-33-ITAZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
已完成
不适用
The effects of ?Avastin in patients with age-related macular degeneratioage-related macular degeneration.Visual disturbances and blindnessH53,H54IRCT2014070218323N1Birjand University of Medical Sciences76
进行中（未招募）
不适用
Evaluation of efficacy and safety of Intravitreal bevacizumab versus intravitreal bevacizumab combined with juxtascleral anecortave acetate for the treatment exudative age-related macular degeneration - IVB JSAEUCTR2006-003170-99-ITIVERSITA DEGLI STUDI DI UDINE
Unknown
3 期
Intravitreal injection versus medical treatment for acute CSREye DiseasesPACTR202204601902304Suez Canal University Hospital45